$4.40
0.133.04%
At Close: -
$4.40
00.00%
After Hours: 4:04 PM EDT
15 minutes delayed
Boundless Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Boundless Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.77 | $-0.80 | 3.75 % |
Sep 2019 | 2019-11-07 | $-1.00 | $-1.07 | 6.54 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Boundless Bio (BOLD) is scheduled to report earnings on November 3, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.77, which beat the estimate of $-0.80.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.